here is growing evidence to support the existence of diabetic cardiomyopathy as a distinct clinical entity that may lead to heart failure independent of coronary artery disease or hypertension (1) . Although there is general agreement that left ventricular (LV) diastolic dysfunction may be present in diabetic patients(2; 3), recent studies utilizing tissue Doppler imaging (TDI) also support the presence of subtle systolic abnormalities in the longitudinal axis (4) . Cardiovascular autonomic neuropathy (CAN) is one of the most serious complications of diabetes and has been weakly linked with LV diastolic dysfunction (5) . Many previous studies that have explored this association suffer from inadequate definitions of CAN and have used conventional Doppler or nuclear techniques to investigate LV diastolic function(6; 7). TDI is a new quantitative tool for the assessment of cardiac systolic function, diastolic function, and the hemodynamics of LV filling (8) . TDI-derived diastolic velocities are less influenced by preload and do not pseudo-normalize in the same way as transmitral flow. We sought to investigate conventional and TDI-derived indices of LV systolic and diastolic function in type 1 patients with and without CAN, and also in normal control subjects.
RESEARCH DESIGN AND METHODS
Forty-four type 1 patients and twenty-one healthy normal volunteers comprised the study population. The study was approved by our Institutional Ethics Committee and all subjects gave written informed consent. All diabetic patients were asymptomatic, had normal ECG (sinus rhythm) and were selected to be normotensive (blood pressure < 130/85 mmHg) without microvascular complications. They also had normal renal function, without microalbuminuria, and took no medication other than insulin. Coronary artery disease was excluded on the basis of a normal thallium-201 myocardial stress test. Other exclusion criteria were: poor quality echocardiographic imaging, valvular heart disease and conduction or rhythm disturbances. Autonomic nervous function (ANF) was assessed according to the consensus statement of American Diabetes Association and the American Academy of Neurology (9) taking into account various factors such as drug use, concomitant illness, and lifestyle issues (exercise, smoking, and caffeine intake). The following tests were performed as previously described (6):
• Beat-to-beat variation of R-R interval assessed by: 1) expiration/inspiration index; 2) mean circular resultant, vector analysis; and 3) standard deviation of R-R intervals.
• Valsalva index.
• Variation of R-R interval during postural change (30:15 index).
• Variation of systolic blood pressure during postural change (standing). The presence of definite CAN was established if at least two of the above mentioned ANF tests were abnormal. The normal values we adopted were those set by Ziegler and colleagues (10) . Non-diabetic controls were healthy asymptomatic subjects with no history of cardiac disease, hypertension, or other cardiac risk factors, who had normal resting and exercise 12-lead ECG. Each subject underwent echocardiographic examination using a standard commercial ultrasound machine (Vivid 7; GE Vingmed, Horten, Norway) with a 1.7-3.4 MHz phased array transducer. The evaluation included measurements of LV ejection fraction by modified Simpson's biplane method; conventional Doppler parameters of diastolic function [early (E) and late (A) peak transmittal diastolic flow velocities] and pulsed TDI to assess longitudinal myocardial T function in the lateral mitral annulus as previously described(3; 11). The following TDI variables were evaluated: peak systolic velocity (S m ), peak early diastolic velocity (E m ), and peak late diastolic velocity (A m ). Comparisons between the 3 groups were carried out with ANOVA, with post hoc analysis (Bonferroni). An unpaired t-test was used to compare continuous variables (duration of diabetes, microalbuminuria) between the diabetic groups. Correlations between the number of ANF tests and continuous variables were tested by Spearman's correlation coefficient (r s ). All analyses were performed using SPSS 14 (SPSS Inc., Chicago,IL,USA). A p-value < 0.05 was considered significant.
RESULTS
Eighteen diabetic patients had at least two abnormal ANF tests. There were no significant differences amongst the three groups with regard to age, sex, duration of diabetes, heart rate, systolic and diastolic blood pressure (Table 1) . Similarly, there were no significant differences in LV systolic function as measured by either 2-D echocardiography (ejection fraction) or TDI (Sm). Glycemic control as assessed by HbA1c was worse in diabetic patients with definite CAN. There were also significant differences between the three groups in measures of LV diastolic function, both, conventional (mitral A velocity, E/A ratio) and TDI derived indices (Em, Am, Em/Am ratio). From post hoc analysis, only the TDI derived Em/Am ratio differed between CAN (+) and CAN (-) diabetic patients. Again, diabetic subjects with definite CAN showed the greatest diastolic impairment. There was a significant correlation between the number of abnormal ANF tests and duration of diabetes (r s = 0.44, p= 0.004), E/A ratio (r s = -0.38, p= 0.014) and Em/Am ratio (r s = -0.41, p= 0.007).
CONCLUSIONS
Our study demonstrates an association between the existence of CAN and LV diastolic dysfunction. The principal finding is that diabetic subjects with CAN have a greater impairment of diastolic function than subjects without CAN, or non-diabetic controls.
Importantly, the significant difference in LV diastolic performance between the two groups of diabetic subjects was identified only with TDI. On the contrary, LV systolic function in type 1 diabetic subjects seems to be unimpaired compared to normal controls, irrespective of the presence of CAN. Therefore, compared with other echocardiographic approaches in the evaluation of LV myocardial function in diabetic patients, TDI seems to be the preferred modality as it is more sensitive and less dependent on confounders such as preload or respiratory variation. The presence of CAN seems to have an additive effect on the impairment in LV diastolic function in type 1 diabetes. It is tempting to speculate that since age and duration of diabetes did not differ in our diabetic groups, the further deterioration in LV diastolic function could be attributed to CAN. Nevertheless, metabolic control comes also into play, and it is difficult to exclude the poorer glycemic control in CAN (+) diabetic patients as a possible explanation of the greater degree of LV diastolic dysfunction. In any case strict glycemic control, careful testing for CAN and frequent echocardiographic assessment for the presence of LV diastolic dysfunction are imperative in type 1 patients. 
